GOPREVY Trademark

Trademark Overview


On Wednesday, February 19, 2020, a trademark application was filed for GOPREVY with the United States Patent and Trademark Office. The USPTO has given the GOPREVY trademark a serial number of 79282294. The federal status of this trademark filing is REGISTERED as of Tuesday, September 1, 2020. This trademark is owned by Glaxo Group Limited. The GOPREVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; all of the foregoing expressly excluding vaccines, pharmaceutical preparations for the prevention and/or treatment of infectious diseases and disorders, and pharmaceutical preparations for the prevention and/or treatment of pneumococcal disease and/or pneumonia
goprevy

General Information


Serial Number79282294
Word MarkGOPREVY
Filing DateWednesday, February 19, 2020
Status700 - REGISTERED
Status DateTuesday, September 1, 2020
Registration Number6138839
Registration DateTuesday, September 1, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; all of the foregoing expressly excluding vaccines, pharmaceutical preparations for the prevention and/or treatment of infectious diseases and disorders, and pharmaceutical preparations for the prevention and/or treatment of pneumococcal disease and/or pneumonia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, April 2, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, April 4, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, April 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 11, 2020APPLICATION FILING RECEIPT MAILED
Thursday, May 7, 2020ASSIGNED TO EXAMINER
Wednesday, May 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 17, 2020ASSIGNED TO PETITION STAFF
Monday, June 22, 2020POST PUBLICATION AMENDMENT - ENTERED
Tuesday, May 19, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, September 1, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, October 28, 2020FINAL DISPOSITION PROCESSED
Sunday, November 1, 2020LIMITATION OF GOODS RECEIVED FROM IB
Friday, November 13, 2020NOTIFICATION PROCESSED BY IB
Friday, May 30, 2025NEW REPRESENTATIVE AT IB RECEIVED
Monday, September 1, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, October 1, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, October 28, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 9, 2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED